Facial lymphoedema as an indicator of terminal disease in oral HIV-associated Kaposi sarcoma.

L. Feller*, R. A. Khammissa, N. H. Wood, R. J. Jose, J. Lemmer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

Rapidly progressive facial lymphoedema developing concurrently with, or immediately after rapid enlargment of oral Kaposi sarcoma (KS) in HIV-seropositive highly active antiretroviral treatment (HAART)-naïve subjects, foretokens death. We present here an unusual case of HIV-KS in an 11-year-old HIV-seropositive HAART-naïve boy. Our patient's KS disease had had a fulminant course characterised by rapidly progressing oral HIV-KS, resorption of the mandibular alveolar bone process beneath some of the HIV-KS lesions, and rapidly progressive facial lymphoedema. He died 3 weeks after the onset of facial lymphoedema.

Original languageEnglish
Pages (from-to)14, 16-18
JournalSADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging
Volume65
Issue number1
Publication statusPublished - Feb 2010

Fingerprint

Dive into the research topics of 'Facial lymphoedema as an indicator of terminal disease in oral HIV-associated Kaposi sarcoma.'. Together they form a unique fingerprint.

Cite this